Oriola-KD Corporation?s Stock Exchange Announcement 30 January 2010 at 3.00 p.m.
In year 2008 Oriola-KD Corporation has published Stock Exchange Releases as
follows:
19.1.2009
Recommendation by the Nomination Committee for proposals by the Board of
Directors to the AGM
30.1.2009
Oriola-KD Corporation's Annual Summary 2008
4.2.2009
Publishing of Oriola-KD Corporation?s financial statements for 2008
12.2.2009
Oriola-KD Corporation?s Financial Statements for 1 January - 31 December 2008
20.2.2009
Oriola-KD Corporation?s 300,000 A-shares converted into B-shares
6.3.2009
Oriola-KD has acquired the minority holding of Organon AB in Kronans Droghandel
AB
19.3.2009
Board of Directors decides on a directed bonus issue as a part of share-based in
19.3.2009
Notice of Annual General Meeting of Oriola-KD Corporation 2009
23.3.2009
Oriola-KD Corporation?s Annual Report for 2008 published
26.3.2009
Oriola-KD Corporation's Board of Directors has decided to change its proposal to
the Annual General Meeting on the issue of stock options
3.4.2009
New General Directors for Oriola-KD?s Russian subsidiaries appointed
14.4.2009
Oriola-KD Corporation's Board of Directors withdraws its proposal to the Annual
General Meeting on the issue of stock options
16.4.2009
Resolutions Passed by Oriola-KD Corporation's Annual General Meeting and by the
Board of Directors
17.4.2009
Oriola-KD?s comparable figures for 2008 based on the new segment structure
22.4.2009
Publishing of Oriola-KD Corporation?s interim report 1 January-31 March 2009
29.4.2009
Oriola-KD Corporation?s interim report for 1 January - 31 March 2009
29.5.2009
Oriola-KD increases the number of key persons belonging to the Oriola-KD Group's
share-based incentive scheme
2.6.2009
Oriola-KD?s directed issue of up to 9.35 million B shares
3.6.2009
Oriola-KD completes the 9.35 million class B shares directed issue to
institutional investors
8.6.2009
Oriola-KD Corporation?s directed issue has been implemented and registered
15.6.2009
Oriola-KD to join forces with KF on the Swedish pharmacy market
29.6.2009
Announcement in accordance with Section 10 of Chapter 2 of the Finnish
Securities Market Act
6.7.2009
Oriola-KD Corporation?s 265,170 A-shares converted into B-shares
27.7.2009
Publishing of Oriola-KD Corporation?s interim report 1 January-30 June 2009
28.7.2009
Preliminary information: Oriola-KD's January-June 2009 operating profit
increased 103 per cent to EUR 25.9 million
13.8.2009
Oriola-KD Corporation?s interim report for 1 January - 30 June 2009
15.9.2009
Oriola-KD Corporation?s 159,674 A-shares converted into B-shares
19.10.2009
Publishing of Oriola-KD Corporation?s interim report 1 January-30 September 2009
29.10.2009
Oriola-KD Corporation?s interim report for 1 January - 30 September 2009
9.11.2009
Oriola-KD to acquire 171 pharmacies in Swedish auction process
12.11.2009
Composition of the Oriola-KD Corporation Nomination Committee
16.11.2009
Publication schedule for Oriola-KD?s financial reporting in 2010
25.11.2009
Oriola-KD Corporation?s 300,000 A-shares converted into B-shares
9.12.2009
Partial demerger of Oriola-KD Corporation's subsidiary Oriola Oy and nominations
in the Oriola-KD Group
16.12.2009
Changes in Oriola-KD Group?s Management Team
Some of the information included in the releases might be out-of-date.
Stock Exchange Releases will be found in Oriola-KD Corporation?s website
www.oriola-kd.com <http://www.oriola-kd.com>.
Oriola-KD Corporation
Eero Hautaniemi
President and CEO
Pellervo Hämäläinen
Vice President, Communications & IR
Distribution:
NASDAQ OMX Helsinki Ltd.
Principal media
Published by:
Oriola-KD Corporation
Corporate Communications
Orionintie 5
FI-02200 Espoo
www.oriola-kd.com <http://www.oriola-kd.com>
[HUG#1370402]
Oriola Oyj, formerly known as Oriola-KD Corporation Oyj, is a Finland-based company active in the pharmaceutical sector. The Company is engaged in the retail and wholesale of pharmaceuticals, acting as a channel between pharmaceutical manufacturers and consumers, primarily in Finland and Sweden. The Company's reporting segments are Consumer, Services, and Healthcare. Through its own pharmacies, the Company provides consumers with not only medicines and pharmaceutical advice but also a selection of healthcare consumer products and customer service. The Company is active through a number of subsidiaries located throughout Europe, including PharmaService OY, Oriola AB, Oriola Oyj, Farenta Oy, Kronans Droghandel Apotek AB and Svensk dos AB.